Guiera / Anti-cancer active substance from a natural environment

MARKET

• From aspirin to anti-cancer drugs, the plant world provides the pharmaceutical industry

with the raw materials for manufacturing a large part of its medicine. Nature is a

consistent source of medication, whether directly isolated from a natural environment or

synthesised with molecules extracted from it.

• Breast cancer is a complex pathology and it is the second leading cancer in females, worldwide.

The market is expanding significantly with global sales valued at $4.95B in 2013.

DESCRIPTION OF THE TECHNOLOGY

• Guieranone B is a molecule isolated from a shrub. Its extraction led to identifying its

chemical structure and to validating an anti-cancer effect in humans.

• Its chemical synthesis is underway.

Competitive ADVANTAGES

• Natural product

• Active molecule identified

• In vitro activity demonstrated